Project Details
| Short title | D9180C00008 |
|---|---|
| Acronym | PROSPERO |
| Status | Active |
| Effective start/end date | 24/04/24 → 17/04/29 |
CTU: A Phase III, Multicentre, Randomised, Double-Blind, Chronic-dosing, Parallel-group, Placebo-controlled Extension Study to Evaluate the Long-term Efficacy and Safety of Tozorakimab in participants with Chronic Obstructive Pulmonary Disease (COPD) with a History of Exacerbations
- Ing, Alvin (Primary Chief Investigator)
- Chester, Catherine (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Martin, Lewis (Clinical Trial Unit Staff)
- TAIDI, Gina (Clinical Trial Unit Staff)
Project: Research